The China-based structural heart technology developer designed LuX-Valve Plus, its proprietary, second-generation transvenous tricuspid valve replacement (TTVR) system, to treat patients with severe tricuspid regurgitation (TR).

Jenscare says that the valve works by functionally replacing the patient’s dysfunctional native tricuspid valve with a prosthetic valve stent. It does not require conventional open-heart surgery, using a transvascular delivery system approach.